Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 3
Submit an article Journal homepage
4,967
Views
112
CrossRef citations to date
0
Altmetric
Original research

Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays

Marie TosoliniCentre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France;INSERM U1037-Université Paul Sabatier-CNRS ERL5294, Université de Toulouse, Toulouse, France;Laboratoire d'Excellence TOUCAN, Toulouse, France;Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Toulouse, France;Pôle Technologique du Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France;Institut Universitaire du Cancer de Toulouse (IUCT), Toulouse, FranceORCID Iconhttp://orcid.org/0000-0001-5278-5952
ORCID Icon,
Frédéric PontCentre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France;INSERM U1037-Université Paul Sabatier-CNRS ERL5294, Université de Toulouse, Toulouse, France;Pôle Technologique du Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France
,
Mary PoupotCentre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France;INSERM U1037-Université Paul Sabatier-CNRS ERL5294, Université de Toulouse, Toulouse, France;Laboratoire d'Excellence TOUCAN, Toulouse, France;Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Toulouse, France
,
François VergezCentre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France;INSERM U1037-Université Paul Sabatier-CNRS ERL5294, Université de Toulouse, Toulouse, France;Institut Universitaire du Cancer de Toulouse (IUCT), Toulouse, France
,
Marie-Laure Nicolau-TraversInstitut Universitaire du Cancer de Toulouse (IUCT), Toulouse, France
,
David VermijlenDepartment of Biopharmacy and Institute for Medical Immunology (IMI), Université Libre de Bruxelles, Bruxelles, Belgium
,
Jean- Emmanuel SarryCentre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France;INSERM U1037-Université Paul Sabatier-CNRS ERL5294, Université de Toulouse, Toulouse, France;Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Toulouse, France
,
Francesco DieliCentral Laboratory for Advanced Diagnostics and Biomedical Research (CLADIBIOR), University of Palermo, Palermo, Italy
&
Jean-Jacques FourniéCentre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France;INSERM U1037-Université Paul Sabatier-CNRS ERL5294, Université de Toulouse, Toulouse, France;Laboratoire d'Excellence TOUCAN, Toulouse, France;Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Toulouse, FranceCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-6542-6908
ORCID Icon show all
Article: e1284723 | Received 22 Dec 2016, Accepted 13 Jan 2017, Published online: 30 Mar 2017

Citations (112)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Rebecca P Chen, Kenta Shinoda, Pragya Rampuria, Fang Jin, Tin Bartholomew, Chunxia Zhao, Fan Yang & Javier Chaparro-Riggers. (2022) Bispecific antibodies for immune cell retargeting against cancer. Expert Opinion on Biological Therapy 22:8, pages 965-982.
Read now
Juan-Pablo Cerapio, Marion Perrier, Camille-Charlotte Balança, Pauline Gravelle, Fréderic Pont, Christel Devaud, Don-Marc Franchini, Virginie Féliu, Marie Tosolini, Carine Valle, Fréderic Lopez, Anne Quillet-Mary, Loic Ysebaert, Alejandra Martinez, Jean Pierre Delord, Maha Ayyoub, Camille Laurent & Jean-Jacques Fournie. (2021) Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancers. OncoImmunology 10:1.
Read now
Elena Lo Presti, Anna Maria Corsale, Francesco Dieli & Serena Meraviglia. (2019) γδ cell-based immunotherapy for cancer. Expert Opinion on Biological Therapy 19:9, pages 887-895.
Read now
Cédric Rossi, Pauline Gravelle, Emilie Decaup, Julie Bordenave, Mary Poupot, Marie Tosolini, Don-Marc Franchini, Camille Laurent, Renaud Morin, Jean-Michel Lagarde, Loïc Ysebaert, Laetitia Ligat, Christine Jean, Ariel Savina, Christian Klein, Alba Matas Céspedes, Patricia Perez-Galan, Jean-Jacques Fournié & Christine Bezombes. (2019) Boosting γδ T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma. OncoImmunology 8:3.
Read now
Clément Barjon, Henri-Alexandre Michaud, Angeline Fages, Cécile Dejou, Alexandre Zampieri, Laetitia They, Aurélie Gennetier, Françoise Sanchez, Laurent Gros, Jean-François Eliaou, Nathalie Bonnefoy & Virginie Lafont. (2018) IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population. OncoImmunology 7:1.
Read now
S. Meraviglia, E. Lo Presti, M. Tosolini, C. La Mendola, V. Orlando, M. Todaro, V. Catalano, G. Stassi, G. Cicero, S. Vieni, J. J. Fourniè & F. Dieli. (2017) Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer. OncoImmunology 6:10.
Read now

Articles from other publishers (106)

Wenyi Yan, Louisa S. Chard Dunmall, Nicholas R. Lemoine, Yaohe Wang, Yafeng Wang & Pengju Wang. (2023) The capability of heterogeneous γδ T cells in cancer treatment. Frontiers in Immunology 14.
Crossref
Yi Hu, Qinglin Hu, Yongsheng Li, Ligong Lu, Zheng Xiang, Zhinan Yin, Dieter Kabelitz & Yangzhe Wu. (2023) γδ T cells: origin and fate, subsets, diseases and immunotherapy. Signal Transduction and Targeted Therapy 8:1.
Crossref
Andrea K. Miyahira & Howard R. Soule. (2023) The 29th Annual Prostate Cancer Foundation Scientific Retreat Report. The Prostate.
Crossref
Rulan Ma, Meijun Gong, Tuanhe Sun, Lin Su & Kang Li. (2023) The prognostic role of γδ T cells in colorectal cancer based on nomogram. European Journal of Medical Research 28:1.
Crossref
Ariel A. Hippen, Dalia K. Omran, Lukas M. Weber, Euihye Jung, Ronny Drapkin, Jennifer A. Doherty, Stephanie C. Hicks & Casey S. Greene. (2023) Performance of computational algorithms to deconvolve heterogeneous bulk ovarian tumor tissue depends on experimental factors. Genome Biology 24:1.
Crossref
Carla Faria, Fabien Gava, Pauline Gravelle, Juan Garcia Valero, Celia Dobaño-López, Nathalie Van Acker, Cathy Quelen, Gael Jalowicki, Renaud Morin, Cédric Rossi, Jean-Michel Lagarde, Jean-Jacques Fournié, Loïc Ysebaert, Camille Laurent, Patricia Pérez-Galán & Christine Bezombes. (2023) Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine. Journal for ImmunoTherapy of Cancer 11:10, pages e007156.
Crossref
Lisa A. King, Elisa C. Toffoli, Myrthe Veth, Victoria Iglesias-Guimarais, Manon C. Slot, Derk Amsen, Rieneke van de Ven, Sarah Derks, Marieke F. Fransen, Jurriaan B. Tuynman, Thilo Riedl, Rob C. Roovers, Anton E.P. Adang, Jurjen M. Ruben, Paul W.H.I. Parren, Tanja D. de Gruijl & Hans J. van der Vliet. (2023) A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors. Cancer Immunology Research 11:9, pages 1237-1252.
Crossref
Andrew Kent, Lyndsey S. Crump & Eduardo Davila. (2023) Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML. Frontiers in Immunology 14.
Crossref
Ge Tan, Katelyn M. Spillane & John Maher. (2023) The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer. Biology 12:8, pages 1079.
Crossref
Mahda Delshad, Mohammad Amin Omrani, Atieh Pourbagheri-Sigaroodi & Davood Bashash. (2023) Oncology in the modern era: Artificial Intelligence is reshaping cancer diagnosis, prognosis and treatment. Iranian Journal of Blood and Cancer 15:3, pages 13-41.
Crossref
Ziwen Zheng, Thomas Wieder, Bernhard Mauerer, Luisa Schäfer, Rebecca Kesselring & Heidi Braumüller. (2023) T Cells in Colorectal Cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment. International Journal of Molecular Sciences 24:14, pages 11673.
Crossref
Anne-Charlotte Le Floch, Marie-Sarah Rouvière, Nassim Salem, Amira Ben Amara, Florence Orlanducci, Norbert Vey, Laurent Gorvel, Anne-Sophie Chretien & Daniel Olive. (2023) Prognostic Immune Effector Signature in Adult Acute Lymphoblastic Leukemia Patients Is Dominated by γδ T Cells. Cells 12:13, pages 1693.
Crossref
Katrin Raute, Juliane Strietz, Maria Alejandra Parigiani, Geoffroy Andrieux, Oliver S. Thomas, Klaus M. Kistner, Marina Zintchenko, Peter Aichele, Maike Hofmann, Houjiang Zhou, Wilfried Weber, Melanie Boerries, Mahima Swamy, Jochen Maurer & Susana Minguet. (2023) Breast Cancer Stem Cell–Derived Tumors Escape from γδ T-cell Immunosurveillance In Vivo by Modulating γδ T-cell Ligands . Cancer Immunology Research 11:6, pages 810-829.
Crossref
Shi‐Wei Huang, Chih‐Ming Pan, Yu‐Chuan Lin, Mei‐Chih Chen, Yeh Chen, Chia‐Ing Jan, Chung‐Chun Wu, Fang‐Yu Lin, Sin‐Ting Wang, Chen‐Yu Lin, Pei‐Ying Lin, Wei‐Hsaing Huang, Yu‐Ting Chiang, Wan‐Chen Tsai, Ya‐Hsu Chiu, Ting‐Hsun Lin, Shao‐Chih Chiu & Der‐Yang Cho. (2023) BiTE‐Secreting CAR‐ γδ T as a Dual Targeting Strategy for the Treatment of Solid Tumors . Advanced Science 10:17.
Crossref
Guillem Sanchez Sanchez, Yohannes Tafesse, Maria Papadopoulou & David Vermijlen. (2023) Surfing on the waves of the human γδ T cell ontogenic sea. Immunological Reviews 315:1, pages 89-107.
Crossref
Zhe Zhang & Xiawei Wei. (2023) Artificial intelligence-assisted selection and efficacy prediction of antineoplastic strategies for precision cancer therapy. Seminars in Cancer Biology 90, pages 57-72.
Crossref
Muzamil Y. Want, Zeenat Bashir & Rauf A. Najar. (2023) T Cell Based Immunotherapy for Cancer: Approaches and Strategies. Vaccines 11:4, pages 835.
Crossref
Chiara Rancan, Marcel Arias-Badia, Pranay Dogra, Brandon Chen, Dvir Aran, Hai Yang, Diamond Luong, Arielle Ilano, Jacky Li, Hewitt Chang, Serena S. Kwek, Li Zhang, Lewis L. Lanier, Maxwell V. Meng, Donna L. Farber & Lawrence Fong. (2023) Exhausted intratumoral Vδ2− γδ T cells in human kidney cancer retain effector function. Nature Immunology 24:4, pages 612-624.
Crossref
Haoran Zheng, Yimeng Li, Yujia Zhao & Aimin Jiang. (2023) Single-cell and bulk RNA sequencing identifies T cell marker genes score to predict the prognosis of pancreatic ductal adenocarcinoma. Scientific Reports 13:1.
Crossref
Roeland Lameris, Jurjen M. Ruben, Victoria Iglesias-Guimarais, Milon de Jong, Myrthe Veth, Fleur S. van de Bovenkamp, Iris de Weerdt, Arnon P. Kater, Sonja Zweegman, Sjeng Horbach, Thilo Riedl, Benjamin Winograd, Rob C. Roovers, Anton E.P. Adang, Tanja D. de Gruijl, Paul W.H.I. Parren & Hans J. van der Vliet. (2023) A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies. Cell Reports Medicine 4:3, pages 100961.
Crossref
Valentina Cazzetta, Delphine Depierreux, Francesco Colucci, Joanna Mikulak & Domenico Mavilio. (2023) NKG2A Immune Checkpoint in Vδ2 T Cells: Emerging Application in Cancer Immunotherapy. Cancers 15:4, pages 1264.
Crossref
Raúl Muñoz Velasco, Ana García García, Paula Jiménez Sánchez, Inmaculada Montanuy Sellart & Víctor Javier Sánchez-Arévalo Lobo. (2022) Tumour microenvironment and heterotypic interactions in pancreatic cancer. Journal of Physiology and Biochemistry 79:1, pages 179-192.
Crossref
Yi-Fei Li, Qiong-Qiong Hou, Shuang Zhao, Xiaoyan Chen, Min Tang & Lin Li. (2022) Identification of tumor-specific neoantigens and immune clusters of hepatocellular carcinoma for mRNA vaccine development. Journal of Cancer Research and Clinical Oncology 149:2, pages 623-637.
Crossref
Anna Maria Corsale, Marta Di Simone, Elena Lo Presti, Francesco Dieli & Serena Meraviglia. (2023) γδ T cells and their clinical application in colon cancer. Frontiers in Immunology 14.
Crossref
Chirine Rafia, Clément Loizeau, Ophélie Renoult, Christelle Harly, Claire Pecqueur, Noémie Joalland & Emmanuel Scotet. (2023) The antitumor activity of human Vγ9Vδ2 T cells is impaired by TGF-β through significant phenotype, transcriptomic and metabolic changes. Frontiers in Immunology 13.
Crossref
Jincai Yang, Lili Yu, Jianchen Man, Huiling Chen, Lanxia Zhou & Li Zhao. (2022) Immune scoring model based on immune cell infiltration to predict prognosis in diffuse large B‐cell lymphoma. Cancer 129:2, pages 235-244.
Crossref
Vasudevaraju Padmaraju, Yogitha Sankla & Rama Rao Malla. (2023) Role of γδ T Cells in Cancer Progression and Therapy. Critical Reviews™ in Oncogenesis 28:4, pages 59-70.
Crossref
Jennifer Cable, Erica Ollmann Saphire, Adrian C. Hayday, Timothy D. Wiltshire, Jarrod J. Mousa, David P. Humphreys, Esther C. W. Breij, Pierre Bruhns, Matteo Broketa, Genta Furuya, Blake M. Hauser, Matthieu Mahévas, Andrea Carfi, Tineke Cantaert, Peter D. Kwong, Prabhanshu Tripathi, Jonathan H. Davis, Neil Brewis, Bruce A. Keyt, Felix L. Fennemann, Vincent Dussupt, Arvind Sivasubramanian, Philip M. Kim, Reda Rawi, Eve Richardson, Daniel Leventhal, Rachael M. Wolters, Cecile A. W. Geuijen, Matthew A. Sleeman, Niccolo Pengo & Francesca Rose Donnellan. (2022) Antibodies as drugs—a Keystone Symposia report. Annals of the New York Academy of Sciences 1519:1, pages 153-166.
Crossref
Justin C. Boucher, Bin Yu, Gongbo Li, Bishwas Shrestha, David Sallman, Ana Marie Landin, Cheryl Cox, Kumar Karyampudi, Claudio Anasetti, Marco L. Davila & Nelli Bejanyan. (2023) Large Scale Ex Vivo Expansion of γδ T cells Using Artificial Antigen-presenting Cells. Journal of Immunotherapy 46:1, pages 5-13.
Crossref
Yuhan Yang, Yunuo Zhao, Xici Liu & Juan Huang. (2022) Artificial intelligence for prediction of response to cancer immunotherapy. Seminars in Cancer Biology 87, pages 137-147.
Crossref
Marta Sanz, Brendan T. Mann, Alisha Chitrakar & Natalia Soriano-Sarabia. (2022) Human Vδ2 T Cells and Their Versatility for Immunotherapeutic Approaches. Cells 11:22, pages 3572.
Crossref
Guillem Sanchez Sanchez, Maria Papadopoulou, Abdulkader Azouz, Yohannes Tafesse, Archita Mishra, Jerry K. Y. Chan, Yiping Fan, Isoline Verdebout, Silvana Porco, Frédérick Libert, Florent Ginhoux, Bart Vandekerckhove, Stanislas Goriely & David Vermijlen. (2022) Identification of distinct functional thymic programming of fetal and pediatric human γδ thymocytes via single-cell analysis. Nature Communications 13:1.
Crossref
Yawei Li, Xin Wu, Ping Yang, Guoqian Jiang & Yuan Luo. (2022) Machine Learning for Lung Cancer Diagnosis, Treatment, and Prognosis. Genomics, Proteomics & Bioinformatics 20:5, pages 850-866.
Crossref
Chen Su, Zeyang Lin, Yongmei Cui, Jian-Chun Cai & Jingjing Hou. (2022) Identification of Essential Tumor-Infiltrating Immune Cells and Relevant Genes in Left-Sided and Right-Sided Colon Cancers. Cancers 14:19, pages 4713.
Crossref
Sylvain Nguyen, Mathieu F Chevalier, Sulayman Benmerzoug, Valérie Cesson, Anna K Schneider, Sonia-Cristina Rodrigues-Dias, Florence Dartiguenave, Ilaria Lucca, Patrice Jichlinski, Beat Roth, Denise Nardelli-Haefliger & Laurent Derré. (2022) Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments. Journal for ImmunoTherapy of Cancer 10:8, pages e004880.
Crossref
Fatemeh Nezhad Shamohammadi, Mahboubeh Yazdanifar, Mona Oraei, Mohammad H Kazemi, Azam Roohi, Seyedeh Mahya Shariat razavi, Farhad Rezaei, Farzad Parvizpour, Yalda Karamlou & Haideh Namdari. (2022) Controversial role of γδ T cells in pancreatic cancer. International Immunopharmacology 108, pages 108895.
Crossref
Rui Yang, Qing He, Hui Zhou, Cheng Gong, Xing Wang, Xingpan Song, Fang Luo, Yang Lei, Qian Ni, Zili Wang, Shasha Xu, Yan Xue, Man Zhang, Haimei Wen, Lijuan Fang, Liang Zeng, Yongxiang Yan, Jian Shi, Jing Zhang, Jizu Yi & Pengfei Zhou. (2022) Vγ2 x PD-L1, a Bispecific Antibody Targeting Both the Vγ2 TCR and PD-L1, Improves the Anti-Tumor Response of Vγ2Vδ2 T Cell. Frontiers in Immunology 13.
Crossref
José Saura-Esteller, Milon de Jong, Lisa A. King, Erik Ensing, Benjamin Winograd, Tanja D. de Gruijl, Paul W. H. I. Parren & Hans J. van der Vliet. (2022) Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future. Frontiers in Immunology 13.
Crossref
Alessandro Allegra, Marco Casciaro, Elena Lo Presti, Caterina Musolino & Sebastiano Gangemi. (2022) Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy. Biomolecules 12:6, pages 754.
Crossref
Jaydeep Bhat, Katarzyna Placek & Simon Faissner. (2022) Contemplating Dichotomous Nature of Gamma Delta T Cells for Immunotherapy. Frontiers in Immunology 13.
Crossref
Ruoyu Dong, Yixi Zhang, Haowen Xiao & Xun Zeng. (2022) Engineering γδ T Cells: Recognizing and Activating on Their Own Way. Frontiers in Immunology 13.
Crossref
Nekisa Zakeri, Andrew Hall, Leo Swadling, Laura J. Pallett, Nathalie M. Schmidt, Mariana O. Diniz, Stephanie Kucykowicz, Oliver E. Amin, Amir Gander, Massimo Pinzani, Brian R. Davidson, Alberto Quaglia & Mala K. Maini. (2022) Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma. Nature Communications 13:1.
Crossref
Jiechu Deng & Hongna Yin. (2022) Gamma delta (γδ) T cells in cancer immunotherapy; where it comes from, where it will go?. European Journal of Pharmacology 919, pages 174803.
Crossref
Xuelian Song, Changran Wei & Xiangqi Li. (2022) Association between γδ T cells and clinicopathological features of breast cancer. International Immunopharmacology 103, pages 108457.
Crossref
Chao Wang, Yan Zhang & Wei-Qiang Gao. (2022) The evolving role of immune cells in prostate cancer. Cancer Letters 525, pages 9-21.
Crossref
Sara Pizzamiglio, Chiara Maura Ciniselli, Tiziana Triulzi, Chiara Gargiuli, Loris De Cecco, Evandro de Azambuja, Debora Fumagalli, Christos Sotiriou, Nadia Harbeck, Miguel Izquierdo, Paolo Nuciforo, Jens Huober, Vera Cappelletti, Saverio Cinieri, Martine Piccart, Maria Grazia Daidone, Giancarlo Pruneri, Mario Paolo Colombo, Elda Tagliabue, Paolo Verderio & Serena Di Cosimo. (2021) Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis. Clinical Cancer Research 27:23, pages 6307-6313.
Crossref
Richard E. Beatson, Ana C. Parente-Pereira, Leena Halim, Domenico Cozzetto, Caroline Hull, Lynsey M. Whilding, Olivier Martinez, Chelsea A. Taylor, Jana Obajdin, Kim Ngan Luu Hoang, Benjamin Draper, Ayesha Iqbal, Tom Hardiman, Tomasz Zabinski, Francis Man, Rafael T.M. de Rosales, Jinger Xie, Fred Aswad, Daniela Achkova, Chung-Yang Ricardo Joseph, Sara Ciprut, Antonella Adami, Helge G. Roider, Holger Hess-Stumpp, Balázs Győrffy, Jelmar Quist, Anita Grigoriadis, Anette Sommer, Andrew N.J. Tutt, David M. Davies & John Maher. (2021) TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancer. Cell Reports Medicine 2:12, pages 100473.
Crossref
Yu-Cheng Chang, Yi-Hao Chiang, Kate Hsu, Chih-Kuang Chuang, Chen-Wei Kao, Yi-Fang Chang, Ming-Chih Chang, Ken-Hong Lim, Hung-I Cheng, Yen-Ning Hsu & Caleb G. Chen. (2021) Activated naïve γδ T cells accelerate deep molecular response to BCR-ABL inhibitors in patients with chronic myeloid leukemia. Blood Cancer Journal 11:11.
Crossref
Léonce Kouakanou, Christian Peters, Christine E. Brown, Dieter Kabelitz & Leo D. Wang. (2021) Vitamin C, From Supplement to Treatment: A Re-Emerging Adjunct for Cancer Immunotherapy?. Frontiers in Immunology 12.
Crossref
Zhijie Xu, Xiang Wang, Shuangshuang Zeng, Xinxin Ren, Yuanliang Yan & Zhicheng Gong. (2021) Applying artificial intelligence for cancer immunotherapy. Acta Pharmaceutica Sinica B 11:11, pages 3393-3405.
Crossref
Mateus de Souza Barros, Nilberto Dias de Araújo, Fábio Magalhães-Gama, Thaís Lohana Pereira Ribeiro, Fabíola Silva Alves Hanna, Andréa Monteiro Tarragô, Adriana Malheiro & Allyson Guimarães Costa. (2021) γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends. Frontiers in Immunology 12.
Crossref
Marc Rigau, Adam P. Uldrich & Andreas Behren. (2021) Targeting butyrophilins for cancer immunotherapy. Trends in Immunology 42:8, pages 670-680.
Crossref
Ashanty M. Melo, Eimear Mylod, Vivienne Fitzgerald, Noel E. Donlon, Dearbhla M. Murphy, Emma K. Foley, Anshul Bhardwaj, John V. Reynolds, Derek G. Doherty, Joanne Lysaght, Margaret R. Dunne & Melissa J. Conroy. (2021) Tissue distribution of γδ T cell subsets in oesophageal adenocarcinoma. Clinical Immunology 229, pages 108797.
Crossref
Dieter Kabelitz. (2021) Perspektiven von γδ-T-Zellen für die Krebs-Immuntherapie. Trillium Immunologie 5:2, pages 105-109.
Crossref
Nicholas A. Gherardin, Kelly Waldeck, Alex Caneborg, Luciano G. Martelotto, Shiva Balachander, Magnus Zethoven, Pasquale M. Petrone, Andrew Pattison, James S. Wilmott, Sergio M. Quiñones-Parra, Fernando Rossello, Atara Posner, Annie Wong, Alison M. Weppler, Kerwin F. Shannon, Angela Hong, Peter M. Ferguson, Valerie Jakrot, Jeanette Raleigh, Athena Hatzimihalis, Paul J. Neeson, Paolo Deleso, Meredith Johnston, Margaret Chua, Juergen C. Becker, Shahneen Sandhu, Grant A. McArthur, Anthony J. Gill, Richard A. Scolyer, Rodney J. Hicks, Dale I. Godfrey & Richard W. Tothill. (2021) γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival. Cancer Immunology Research 9:6, pages 612-623.
Crossref
Elena Lo Presti, Anna Maria Corsale, Marta Di Simone, Francesco Dieli & Serena Meraviglia. (2021) Characterisation of γδ T cells infiltrating colorectal cancer. Gut 70:5, pages 1001-1003.
Crossref
Rueyhung R. Weng, Hsuan-Hsuan Lu, Chien-Ting Lin, Chia-Chi Fan, Rong-Shan Lin, Tai-Chung Huang, Shu-Yung Lin, Yi-Jhen Huang, Yi-Hsiu Juan, Yi-Chieh Wu, Zheng-Ci Hung, Chi Liu, Xuan-Hui Lin, Wan-Chen Hsieh, Tzu-Yuan Chiu, Jung-Chi Liao, Yen-Ling Chiu, Shih-Yu Chen, Chong-Jen Yu & Hsing-Chen Tsai. (2021) Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer. Nature Communications 12:1.
Crossref
Juan Pablo Cerapio, Agnès Marchio, Luis Cano, Ignacio López, Jean-Jacques Fournié, Béatrice Régnault, Sandro Casavilca-Zambrano, Eloy Ruiz, Anne Dejean, Stéphane Bertani & Pascal Pineau. (2021) Global DNA hypermethylation pattern and unique gene expression signature in liver cancer from patients with Indigenous American ancestry. Oncotarget 12:5, pages 475-492.
Crossref
SVETLANA BUNIMOVICH-MENDRAZITSKY & LEONID SHAIKHET. (2021) STABILITY ANALYSIS OF A MATHEMATICAL MODEL FOR CHRONIC MYELOID LEUKEMIA ERADICATION. Journal of Biological Systems 29:01, pages 169-191.
Crossref
Florence Boissière-Michot, Ghita Chabab, Caroline Mollevi, Séverine Guiu, Evelyne Lopez-Crapez, Jeanne Ramos, Nathalie Bonnefoy, Virginie Lafont & William Jacot. (2021) Clinicopathological Correlates of γδ T Cell Infiltration in Triple-Negative Breast Cancer. Cancers 13:4, pages 765.
Crossref
Yan Xu, Zheng Xiang, Mohammed Alnaggar, Léonce Kouakanou, Jiawei Li, Junyi He, Jiashuang Yang, Yi Hu, Yan Chen, Li Lin, Jianlei Hao, Jingxia Li, Jibing Chen, Man Li, Qingling Wu, Christian Peters, Qinghua Zhou, Jianshuang Li, Yingqing Liang, Xiaohua Wang, Baohui Han, Meili Ma, Dieter Kabelitz, Kecheng Xu, Wenwei Tu, Yangzhe Wu & Zhinan Yin. (2020) Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer. Cellular & Molecular Immunology 18:2, pages 427-439.
Crossref
Stéphane Fattori, Laurent Gorvel, Samuel Granjeaud, Philippe Rochigneux, Marie-Sarah Rouvière, Amira Ben Amara, Nicolas Boucherit, Magali Paul, Marie Mélanie Dauplat, Jeanne Thomassin-Piana, Maria Paciencia-Gros, Morgan Avenin, Jihane Pakradouni, Julien Barrou, Emmanuelle Charafe-Jauffret, Gilles Houvenaeghel, Eric Lambaudie, François Bertucci, Anthony Goncalves, Carole Tarpin, Jacques A. Nunès, Raynier Devillier, Anne-Sophie Chretien & Daniel Olive. (2021) Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2+ γδ T Cell Alterations with Lymph Node Invasion. Cancers 13:3, pages 441.
Crossref
Emelie Foord, Lucas C. M. Arruda, Ahmed Gaballa, Charlotte KlynningMichael Uhlin. (2021) Characterization of ascites- and tumor-infiltrating γδ T cells reveals distinct repertoires and a beneficial role in ovarian cancer. Science Translational Medicine 13:577.
Crossref
义 刘. (2021) Research Progress of Biological Characteristics and Anti-Tumor Immunotherapy of γδ T Cells. World Journal of Cancer Research 11:03, pages 83-90.
Crossref
Iris de Weerdt, Roeland Lameris, George L. Scheffer, Jana Vree, Renate de Boer, Anita G. Stam, Rieneke van de Ven, Mark-David Levin, Steven T. Pals, Rob C. Roovers, Paul W.H.I. Parren, Tanja D. de Gruijl, Arnon P. Kater & Hans J. van der Vliet. (2021) A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell–Mediated Antitumor Responses in Human B-cell Malignancies. Cancer Immunology Research 9:1, pages 50-61.
Crossref
Yixi Zhang, Pan Li, Hongyu Fang, Guocan Wang & Xun Zeng. (2020) Paving the Way Towards Universal Chimeric Antigen Receptor Therapy in Cancer Treatment: Current Landscape and Progress. Frontiers in Immunology 11.
Crossref
Dieter Kabelitz. (2020) Gamma Delta T Cells (γδ T Cells) in Health and Disease: In Memory of Professor Wendy Havran. Cells 9:12, pages 2564.
Crossref
Daniela Wesch, Dieter Kabelitz & Hans‐Heinrich Oberg. (2020) Tumor resistance mechanisms and their consequences on γδ T cell activation. Immunological Reviews 298:1, pages 84-98.
Crossref
Toshiyasu Suzuki, Liam Hayman, Anna Kilbey, Joanne Edwards & Seth B. Coffelt. (2020) Gut γδ T cells as guardians, disruptors, and instigators of cancer. Immunological Reviews 298:1, pages 198-217.
Crossref
Elena Lo Presti, Francesco Dieli, Jean Jacques Fourniè & Serena Meraviglia. (2020) Deciphering human γδ T cell response in cancer: Lessons from tumor‐infiltrating γδ T cells. Immunological Reviews 298:1, pages 153-164.
Crossref
Yukari Kobayashi, Yoshihiro Kushihara, Noriyuki Saito, Shigeo Yamaguchi & Kazuhiro Kakimi. (2020) A novel scoring method based on RNA‐Seq immunograms describing individual cancer‐immunity interactions. Cancer Science 111:11, pages 4031-4040.
Crossref
Ghita Chabab, Clément Barjon, Nathalie Bonnefoy & Virginie Lafont. (2020) Pro-tumor γδ T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy. Frontiers in Immunology 11.
Crossref
Rulan Ma, Dawei Yuan, Yizhan Guo, Rong Yan & Kang Li. (2020) Immune Effects of γδ T Cells in Colorectal Cancer: A Review. Frontiers in Immunology 11.
Crossref
Shaoli Das, Kevin Camphausen & Uma Shankavaram. (2020) Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies. Cancers 12:9, pages 2476.
Crossref
Gustav Johansson, Melita Kaltak, Cristiana Rîmniceanu, Avadhesh K Singh, Jan Lycke, Clas Malmeström, Michael Hühn, Outi Vaarala, Susanna Cardell & Anders Ståhlberg. (2020) Ultrasensitive DNA Immune Repertoire Sequencing Using Unique Molecular Identifiers. Clinical Chemistry 66:9, pages 1228-1237.
Crossref
Dieter Kabelitz, Ruben Serrano, Léonce Kouakanou, Christian Peters & Shirin Kalyan. (2020) Cancer immunotherapy with γδ T cells: many paths ahead of us. Cellular & Molecular Immunology 17:9, pages 925-939.
Crossref
Wei Zhang, Yimin Shen, Huanhuan Huang, Sheng Pan, Jingxin Jiang, Wuzhen Chen, Ting Zhang, Chao Zhang & Chao Ni. (2020) A Rosetta Stone for Breast Cancer: Prognostic Value and Dynamic Regulation of Neutrophil in Tumor Microenvironment. Frontiers in Immunology 11.
Crossref
Ghita Chabab, Florence Boissière-Michot, Caroline Mollevi, Jeanne Ramos, Evelyne Lopez-Crapez, Pierre-Emmanuel Colombo, William Jacot, Nathalie Bonnefoy & Virginie Lafont. (2020) Diversity of Tumor-Infiltrating, γδ T-Cell Abundance in Solid Cancers. Cells 9:6, pages 1537.
Crossref
Gabrielle M. Siegers, Indrani Dutta, Eun Young Kang, Jing Huang, Martin Köbel & Lynne-Marie Postovit. (2020) Aberrantly Expressed Embryonic Protein NODAL Alters Breast Cancer Cell Susceptibility to γδ T Cell Cytotoxicity. Frontiers in Immunology 11.
Crossref
Andrew J. Wiemer. (2020) Structure‐Activity Relationships of Butyrophilin 3 Ligands. ChemMedChem 15:12, pages 1030-1039.
Crossref
Ghita Chabab, Clément Barjon, Naoill Abdellaoui, Lucie Salvador-Prince, Cécile Dejou, Henri-Alexandre Michaud, Florence Boissière-Michot, Evelyne Lopez-Crapez, William Jacot, Didier Pourquier, Nathalie Bonnefoy & Virginie Lafont. (2020) Identification of a regulatory Vδ1 gamma delta T cell subpopulation expressing CD73 in human breast cancer. Journal of Leukocyte Biology 107:6, pages 1057-1067.
Crossref
Chao Ni, Qing-Qing Fang, Wu-Zhen Chen, Jin-Xing Jiang, Zhou Jiang, Jun Ye, Ting Zhang, Liu Yang, Fan-Bo Meng, Wen-Jie Xia, Miaochun Zhong & Jian Huang. (2020) Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+γδ1 Treg cells. Signal Transduction and Targeted Therapy 5:1.
Crossref
Klaus-Peter Künkele, Daniela Wesch, Hans-Heinrich Oberg, Martin Aichinger, Verena Supper & Christoph Baumann. (2020) Vγ9Vδ2 T Cells: Can We Re-Purpose a Potent Anti-Infection Mechanism for Cancer Therapy?. Cells 9:4, pages 829.
Crossref
Dimas Carolina Belisario, Muhlis Akman, Martina Godel, Virginia Campani, Maria Pia Patrizio, Lorena Scotti, Claudia Maria Hattinger, Giuseppe De Rosa, Massimo Donadelli, Massimo Serra, Joanna Kopecka & Chiara Riganti. (2020) ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma. Cells 9:3, pages 647.
Crossref
Emilie Picard, Chris P. Verschoor, Grace W. Ma & Graham Pawelec. (2020) Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer. Frontiers in Immunology 11.
Crossref
Zsolt Sebestyen, Immo Prinz, Julie Déchanet-Merville, Bruno Silva-Santos & Jurgen Kuball. (2019) Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies. Nature Reviews Drug Discovery 19:3, pages 169-184.
Crossref
Kangni Wu, Juan Feng, Yanghui Xiu, Zhifeng Li, Zhijuan Lin, Haijun Zhao, Hanyan Zeng, Weilin Xia, Lian Yu & Bing Xu. (2020) Vδ2 T cell subsets, defined by PD-1 and TIM-3 expression, present varied cytokine responses in acute myeloid leukemia patients. International Immunopharmacology 80, pages 106122.
Crossref
Caroline Imbert & Daniel Olive. 2020. Tumor Microenvironment. Tumor Microenvironment 91 104 .
Samuel G. Katz & Peter M. Rabinovich. 2020. Cell Reprogramming for Immunotherapy. Cell Reprogramming for Immunotherapy 3 44 .
Karen Edelblum, Kenth Gustafsson, Daniel J. Pennington, Benjamin E. Willcox & Julie C. Ribot. (2019) Bordeaux 2018: Wine, Cheese, and γδ T Cells. Frontiers in Immunology 10.
Crossref
Aran F. Labrijn, Maarten L. Janmaat, Janice M. Reichert & Paul W. H. I. Parren. (2019) Bispecific antibodies: a mechanistic review of the pipeline. Nature Reviews Drug Discovery 18:8, pages 585-608.
Crossref
Adrian C. Hayday. (2019) γδ T Cell Update: Adaptate Orchestrators of Immune Surveillance. The Journal of Immunology 203:2, pages 311-320.
Crossref
Joseph Cursons, Fernando Souza-Fonseca-Guimaraes, Momeneh Foroutan, Ashley Anderson, Frédéric Hollande, Soroor Hediyeh-Zadeh, Andreas Behren, Nicholas D. Huntington & Melissa J. Davis. (2019) A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients. Cancer Immunology Research 7:7, pages 1162-1174.
Crossref
Bruno Silva-Santos, Sofia Mensurado & Seth B. Coffelt. (2019) γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer. Nature Reviews Cancer 19:7, pages 392-404.
Crossref
Gabriele PizzolatoHannah KaminskiMarie TosoliniDon-Marc FranchiniFréderic PontFréderic MartinsCarine ValleDelphine LabourdetteSarah CadotAnne Quillet-Mary, Mary PoupotCamille LaurentLoic YsebaertSerena MeravigliaFrancesco Dieli, Pierre MervillePierre Milpied, Julie Déchanet-MervilleJean-Jacques Fournié. (2019) Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes. Proceedings of the National Academy of Sciences 116:24, pages 11906-11915.
Crossref
Yuning Hao, Ming Yan, Blake R. Heath, Yu L. Lei & Yuying Xie. (2019) Fast and robust deconvolution of tumor infiltrating lymphocyte from expression profiles using least trimmed squares. PLOS Computational Biology 15:5, pages e1006976.
Crossref
Mijeong Lee, Chanho Park, Jeongmin Woo, Jinho Kim, Inseong Kho, Do-Hyun Nam, Woong-Yang Park, Yeon-Soo Kim, Doo-Sik Kong, Hye Won Lee & Tae Jin Kim. (2019) Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme. Frontiers in Immunology 10.
Crossref
Elizabeth S. Morrow, Antonia Roseweir & Joanne Edwards. (2019) The role of gamma delta T lymphocytes in breast cancer: a review. Translational Research 203, pages 88-96.
Crossref
Mathilde Raverdeau, Stephen P Cunningham, Cathal Harmon & Lydia Lynch. (2019) γδ T cells in cancer: a small population of lymphocytes with big implications. Clinical & Translational Immunology 8:10.
Crossref
Siyi Gu, Marta T. Borowska, Christopher T. Boughter & Erin J. Adams. (2018) Butyrophilin3A proteins and Vγ9Vδ2 T cell activation. Seminars in Cell & Developmental Biology 84, pages 65-74.
Crossref
Sarah Péricart, Marie Tosolini, Pauline Gravelle, Cédric Rossi, Alexandra Traverse-Glehen, Nadia Amara, Camille Franchet, Elodie Martin, Christine Bezombes, Guy Laurent, Pierre Brousset, Jean-Jacques Fournié & Camille Laurent. (2018) Profiling Immune Escape in Hodgkin’s and Diffuse large B-Cell Lymphomas Using the Transcriptome and Immunostaining. Cancers 10:11, pages 415.
Crossref
Elena Lo Presti, Gabriele Pizzolato, Anna Maria Corsale, Nadia Caccamo, Guido Sireci, Francesco Dieli & Serena Meraviglia. (2018) γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion. Frontiers in Immunology 9.
Crossref
Timm Hoeres, Manfred Smetak, Dominik Pretscher & Martin Wilhelm. (2018) Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer. Frontiers in Immunology 9.
Crossref
Neidy V. Rodrigues, Daniel V. Correia, Sofia Mensurado, Sandrina Nóbrega-Pereira, Ana deBarros, Fernanda Kyle-Cezar, Andrew Tutt, Adrian C. Hayday, Haakan Norell, Bruno Silva-Santos & Sérgio Dias. (2018) Low-Density Lipoprotein Uptake Inhibits the Activation and Antitumor Functions of Human Vγ9Vδ2 T Cells. Cancer Immunology Research 6:4, pages 448-457.
Crossref
Elena Lo Presti, Roberto Di Mitri, Gabriele Pizzolato, Filippo Mocciaro, Francesco Dieli & Serena Meraviglia. (2018) γδ cells and tumor microenvironment: A helpful or a dangerous liason?. Journal of Leukocyte Biology 103:3, pages 485-492.
Crossref
Elena Lo Presti, Gabriele Pizzolato, Eliana Gulotta, Gianfranco Cocorullo, Gaspare Gulotta, Francesco Dieli & Serena Meraviglia. (2017) Current Advances in γδ T Cell-Based Tumor Immunotherapy. Frontiers in Immunology 8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.